Most Cited
-
Original Article2023-09-30
2
1856
466
Investigating the prevalence of and predictive and risk factors for pulmonary embolism in patients with COVID-19 in Nemazee Teaching Hospital
Mahnaz Yadollahi, Hessam Hosseinalipour, Mehrdad Karajizadeh, Muhammad Alinaqi, Pooria Fazeli, Mehrdad Jowkar, Kazem Jamali, Maryam Yadollahi
Blood Res 2023; 58(3): 127-132 -
Letter to the Editor2023-09-30
2
800
343
Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report
Suji Park, Jae-Ryong Shim, Ji Hyun Lee, Jin-Yeong Han
Blood Res 2023; 58(3): 151-155 -
Letter to the Editor2023-09-30
2
1084
389
Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm
Dong Hyun Kim, Ja Min Byun, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon, Youngil Koh
Blood Res 2023; 58(3): 155-157 -
Review Article2023-12-31
2
1587
618
Recent advances in cellular immunotherapy for lymphoid malignancies
Haerim Chung, Hyunsoo Cho
Blood Res 2023; 58(4): 166-172 -
Original Article2023-12-31
2
2576
535
A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
Yong-Pyo Lee, Ye Ji Jung, Junhun Cho, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim, Sang Eun Yoon
Blood Res 2023; 58(4): 208-220 -
Letter to the Editor2023-12-31
2
682
293
Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement
Seo Yoon Jang, Ja Min Byun, Sung-Soo Yoon, Jin Chul Paeng, Seung-Pyo Lee, Youngil Koh
Blood Res 2023; 58(4): 242-245 -
REVIEW2024-02-13
1
1592
238
Genomic technologies for detecting structural variations in hematologic malignancies
Mi‑Ae Jang
Blood Res (2024) 59:1
-
RESEARCH2024-02-19
1
1365
174
Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level
Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai and Suporn Chuncharunee
Blood Res (2024) 59:2 -
REVIEW2024-04-12
1
860
112
-
RESEARCH2024-04-16
1
814
114
Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formation
Omid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar and Nargess Arandi
Blood Res (2024) 59:16
Full Text
Cite
Share
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, Yi Lin Lee, Jameela Sathar, Simon McRae, Amanda Davis, Jennifer Curnow, Robert Bird, Philip Choi, Pantep Angchaisuksiri, Sim Leng Tien, Joyce Ching Mei Lam, Doyeun Oh, Jin Seok Kim, Sung-Soo Yoon, Raymond Siu-Ming Wong, Carolyn Lauren, Eileen Grace Merriman, Anoop Enjeti, Mark Smith, Ross Ian Baker
Blood Res 2023;58: 36-41 -
Transfusion support in hematopoietic stem cell transplantation
Dong Wook Jekarl, Jae Kwon Kim, Jay Ho Han, Howon Lee, Jaeeun Yoo, Jihyang Lim, Yonggoo Kim
Blood Res 2023;58: S1-S7
Most Cited
-
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, Jae-Cheol Jo
Blood Res 2023;58: S90-S95 -
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res 2023;58: S29-S36
Editorial Office
+82-2-516-6582
